Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention Erin D. Michos, MD, MHS, Michael J. Blaha, MD, MPH, Roger S. Blumenthal, MD Mayo Clinic Proceedings Volume 92, Issue 12, Pages 1831-1841 (December 2017) DOI: 10.1016/j.mayocp.2017.10.001 Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Core components of the clinician-patient risk discussion. ASCVD = atherosclerotic cardiovascular disease. Mayo Clinic Proceedings 2017 92, 1831-1841DOI: (10.1016/j.mayocp.2017.10.001) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 2 The coronary artery calcium (CAC) score integrates lifetime exposure of traditional and nontraditional risk factors for atherosclerotic cardiovascular disease. Mayo Clinic Proceedings 2017 92, 1831-1841DOI: (10.1016/j.mayocp.2017.10.001) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 3 Coronary artery calcium (CAC) testing to guide the treatment decisions. Mayo Clinic Proceedings 2017 92, 1831-1841DOI: (10.1016/j.mayocp.2017.10.001) Copyright © 2017 Mayo Foundation for Medical Education and Research Terms and Conditions